Skip to main content


Gilead announces long-awaited price for COVID-19 drug remdesivir

By Stat News  
   June 29, 2020

Since remdesivir became the first medicine shown to have an impact on Covid-19, doctors, politicians, and Wall Street investors have engaged in a tense guessing game: What would its maker, Gilead Sciences, charge for the drug?

Full story

Get the latest on healthcare leadership in your inbox.